Relationship between Atherogenic Dyslipidaemia and Lipid Triad with Different Scales of Overweight and Obesity in 418,343 Spanish Workers
Table 3
Prevalence of elevated values of obesity scales according to AD and LT values by gender.
No AD
AD
No LT
LT
No AD
AD
No LT
LT
Women
Men
n = 165,431
n = 6,851
n = 170,566
n = 1,716
n = 227,030
n = 19,031
n = 240,669
n = 5,392
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
WtHR > 0.50
20.05 (20.00–20.11)
57.47 (55.37–59.61)
21.23 (21.17–21.29)
52.62 (49.58–55.66)
38.47 (38.44–38.50)
77.60 (76.18–79.11)
40.72 (40.70–40.75)
76.08 (73.89–78.30)
BMI obesity
14.80 (14.75–14.82)
53.93 (51.80–56.04)
16.04 (15.99–16.10)
47.55 (44.50–50.61)
15.96 (15.93–16.00)
63.09 (65.58–64.63)
18.71 (18.69–18.73)
59.63 (57.44–61.85)
CUN-BAE obesity
46.17 (46.11–46.21)
88.35 (86.20–90.49)
47.44 (47.38–47.50)
88.11 (85.06–91.18)
48.72 (48.69–48.75)
89.26 (87.74–90.82)
51.02 (51.0–51.05)
89.13 (86.87–91.34)
ECORE-BF obesity
45.18 (45.12–45.24)
87.61 (85.50–89.84)
46.46 (46.40–46.52)
87.18 (84.15–90.23)
48.65 (48.62–48.68)
89.26 (87.73–90.81)
50.95 (50.93–50.97)
89.11 (86.84–91.32)
RFM obesity
32.38 (32.33–32.43)
70.46 (68.33–72.60)
33.56 (33.51–33.62)
67.07 (64.00–70.11)
49.08 (49.05–49.11)
83.64 (82.11–85.12)
51.06 (51.04–51.08)
82.51 (80.30–84.74)
Palafolls obesity
98.41 (98.34–98.48)
95.64 (93.50–97.87)
72.69 (72.62–72.76)
95.51 (92.47–98.54)
86.02 (86.00–86.05)
98.41 (96.90–99.93)
86.71 (86.69–86.74)
98.61 (96.40–100.00)
Deurenberg obesity
67.36 (67.30–67.42)
95.85 (93.60–90.03)
68.21 (68.14–68.28)
96.85 (93.77–99.91)
44.88 (44.85–44.91)
88.23 (86.70–89.75)
47.32 (47.30–47.34).
88.67 (86.47–90.81)
-value in all cases <0.0001. AD: atherogenic dyslipidaemia; LT: lipid triad; BMI: body mass index; WtHR: waist to height ratio; CUN-BAE: University of Navarra Clinic-Body Fat Estimator; ECORE-BF: Equation Córdoba for Estimation of Body Fat; BMI: body mass index; RFM: relative fat mass.
